Jess Scholey

Dr. Jess Scholey

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
HTHoratio R. Thomas
Horatio R. Thomas
XMXin Miao
Xin Miao
DFDianne Ferguson
Dianne Ferguson
CCChristina Calvin
Christina Calvin
UKUday Bhaskar Krishnamurthy
Uday Bhaskar Krishnamurthy
JSJess Scholey
Jess Scholey

8 July 2023 in Cancers
Verified
Journal Article
Open access
PDF file
CJChangzhe Jiao
Changzhe Jiao
DLDiane Ling
Diane Ling
SBShelly Bian
Shelly Bian
AVApril Vassantachart
April Vassantachart
KCKaren Cheng
Karen Cheng
WYWensha Yang
Wensha Yang
Purposes: To provide abdominal contrast-enhanced MR image synthesis, we developed an gradient regularized multi-modal multi-discrimination sparse attention fusion generative adversarial network (GRMM-GAN) to avoid repeated contrast injections to patients and facilitate adaptive monitoring. Methods: With IRB approval, 165 abdominal MR studies from 61 liver cancer patients were retrospectively solicited from our institutional database. Each study included T2, T1 pre-contrast (T1pre), and T1 contrast-enhanced (T1ce) images. The GRMM-GAN synthesis pipeline consists of a sparse attention fusion network, an image gradient regularizer (GR), and a generative adversarial network with multi-discrimination. The studies were randomly divided into 115 for training, 20 for validation, and 30 for testing. The two pre-contrast MR modalities, T2 and T1pre images, were adopted as inputs in the training phase. The T1ce image at the portal venous phase was used as an output. The synthesized T1ce images were compared with the ground truth T1ce images. The evaluation metrics include peak signal-to-noise ratio (PSNR), structural similarity index (SSIM), and mean squared error (MSE). A Turing test and experts’ contours evaluated the image synthesis quality. Results: The proposed GRMM-GAN model achieved a PSNR of 28.56, an SSIM of 0.869, and an MSE of 83.27. The proposed model showed statistically significant improvements in all metrics tested with p-values < 0.05 over the state-of-the-art model comparisons. The average Turing test score was 52.33%, which is close to random guessing, supporting the model’s effectiveness for clinical application. In the tumor-specific region analysis, the average tumor contrast-to-noise ratio (CNR) of the synthesized MR images was not statistically significant from the real MR images. The average DICE from real vs. synthetic images was 0.90 compared to the inter-operator DICE of 0.91. Conclusion: We demonstrated the function of a novel multi-modal MR image synthesis neural network GRMM-GAN for T1ce MR synthesis based on pre-contrast T1 and T2 MR images. GRMM-GAN shows promise for avoiding repeated contrast injections during radiation therapy treatment.

21 December 2023 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
KSKamal Singhrao
Kamal Singhrao
CDCatherine Lu Dugan
Catherine Lu Dugan
CCChristina Calvin
Christina Calvin
LPLuis Pelayo
Luis Pelayo
SYSue Sun Yom
Sue Sun Yom
LSLisa Singer
Lisa Singer
Background: Magnetic resonance image only (MRI‐only) simulation for head and neck (H&N) radiotherapy (RT) could allow for single‐image modality planning with excellent soft tissue contrast. In the MRI‐only simulation workflow, synthetic computed tomography (sCT) is generated from MRI to provide electron density information for dose calculation. Bone/air regions produce little MRI signal which could lead to electron density misclassification in sCT. Establishing the dosimetric impact of this error could inform quality assurance (QA) procedures using MRI‐only RT planning or compensatory methods for accurate dosimetric calculation.Purpose: The aim of this study was to investigate if Hounsfield unit (HU) voxel misassignments from sCT images result in dosimetric errors in clinical treatment plans.Methods: Fourteen H&N cancer patients undergoing same‐day CT and 3T MRI simulation were retrospectively identified. MRI was deformed to the CT using multimodal deformable image registration. sCTs were generated from T1w DIXON MRIs using a commercially available deep learning‐based generator (MRIplanner, Spectronic Medical AB, Helsingborg, Sweden). Tissue voxel assignment was quantified by creating a CT‐derived HU threshold contour. CT/sCT HU differences for anatomical/target contours and tissue classification regions including air (500 HU) were quantified. t‐test was used to determine if sCT/CT HU differences were significant. The frequency of structures that had a HU difference > 80 HU (the CT window‐width setting for intra‐cranial structures) was computed to establish structure classification accuracy. Clinical intensity modulated radiation therapy (IMRT) treatment plans created on CT were retrospectively recalculated on sCT images and compared using the gamma metric.Results: The mean ratio of sCT HUs relative to CT for air, adipose tissue, soft tissue, spongy and cortical bone were 1.7 ± 0.3, 1.1 ± 0.1, 1.0 ± 0.1, 0.9 ± 0.1 and 0.8 ± 0.1 (value of 1 indicates perfect agreement). T‐tests (significance set at t = 0.05) identified differences in HU values for air, spongy and cortical bone in sCT images compared to CT. The structures with sCT/CT HU differences > 80 HU of note were the left and right (L/R) cochlea and mandible (>79% of the tested cohort), the oral cavity (for 57% of the tested cohort), the epiglottis (for 43% of the tested cohort) and the L/R TM joints (occurring > 29% of the cohort). In the case of the cochlea and TM joints, these structures contain dense bone/air interfaces. In the case of the oral cavity and mandible, these structures suffer the additional challenge of being positionally altered in CT versus MRI simulation (due to a non‐MR safe immobilizing bite block requiring absence of bite block in MR). Finally, the epiglottis HU assignment suffers from its small size and unstable positionality. Plans recalculated on sCT yielded global/local gamma pass rates of 95.5% ± 2% (3 mm, 3%) and 92.7% ± 2.1% (2 mm, 2%). The largest mean differences in D95, Dmean, D50 dose volume histogram (DVH) metrics for organ‐at‐risk (OAR) and planning tumor volumes (PTVs) were 2.3% ± 3.0% and 0.7% ± 1.9% respectively.Conclusions: In this cohort, HU differences of CT and sCT were observed but did not translate into a reduction in gamma pass rates or differences in average PTV/OAR dose metrics greater than 3%. For sites such as the H&N where there are many tissue interfaces we did not observe large scale dose deviations but further studies using larger retrospective cohorts are merited to establish the variation in sCT dosimetric accuracy which could help to inform QA limits on clinical sCT usage.

8 August 2022 in Medical Physics
Verified
Journal Article
Closed access
JSJess Scholey
Jess Scholey
ARAbhejit Rajagopal
Abhejit Rajagopal
EVElena Grace Vasquez
Elena Grace Vasquez
ASAtchar Sudhyadhom
Atchar Sudhyadhom
PLPeder Eric Zufall Larson
Peder Eric Zufall Larson

1 July 2020 in Advances in Radiation Oncology
Verified
Journal Article
Open access
KMKavita K. Mishra
Kavita K. Mishra
AAArmin R Afshar
Armin R Afshar
Juliette THARIATJuliette THARIAT
Juliette THARIAT
HSHelen A. Shih
Helen A. Shih
JSJess Scholey
Jess Scholey
Bertil E. DamatoBertil E. Damato
Bertil E. Damato
Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the COVID-19 pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group (PTCOG) is the largest international community of particle/proton therapy providers. Participating experts are/were affiliated with the member institutions of the PTCOG Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of healthcare providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment.

20 November 2020 in Medical Physics
Verified
Journal Article
Closed access
PDF file
JSJess Scholey
Jess Scholey
DCDharshan Chandramohan
Dharshan Chandramohan
TNTarun Naren
Tarun Naren
WLWilliam Liu
William Liu
PLPeder Eric Zufall Larson
Peder Eric Zufall Larson
ASAtchar Sudhyadhom
Atchar Sudhyadhom